Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies | Eli Lilly and Company - investor.lilly.com
The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.